Pfizer’s clinical data puts the US one step closer to a Covid-19 vaccine for younger kids

A Food and Drug Administration review this week determined that Pfizer-BioNTech’s Covid-19 vaccine is safe and effective for children ages 5 to 11, paving the way for a shot to be authorized for that age group as soon as early November.

Pfizer also announced on Friday that the vaccine is…